Abstract
Recent studies of the effects of reserpine on human sleep have reported increased rapid eye movement (REM) sleep, and decreased slow-wave (SW) sleep. These results are relevant to theories linking serotonin and the catecholamines to the control of different stages of sleep. However, since reserpine causes release and subsequent depletion of both monoamines, it is difficult to relate changes in sleep profiles to specific alterations in one or the other amine system. The results to be reported here, when compared to those obtained with other treatments which affect the biogenic amines, encourage the view that level and turnover of serotonin are the primary mediators for reserpine-induced modifications of sleep. In two separate experiments, EEG sleep patterns from 20 male Ss were examined following single and repeated oral doses (1 mg) of reserpine. In the single-dose study, reserpine caused increased REM, and decreased SW sleep, effects which became statistically significant on the post-medication (P-M) recovery session. These changes were accompanied by reduced frequency per minute of sigma spindles (stage 2) decreased eye-movement density (stage REM) and a tendency toward increased brief arousals, especially during stage REM. Examination of parameters of the REM cycle revealed that the potentiation of REM sleep was due to its reduced latency of onset, and more frequent cyclic occurrence, not to increased duration of REM episodes. The results of the repeated-dose study replicated and amplified those of the first experiment, showing that medication caused a progressive increase in the amount of stage REM, accompanied by a simultaneous loss of SW sleep. The increase in REM was again due to acceleration of its cycle rather than lengthening of its episodes. During medication, epochs of stage REM were increasingly interrupted by brief arousals, with a simulteneous decline in the density of rapid eye movements. Most of these reserpine effects persisted into the P-M recovery session.
The acceleration of the REM cycle, loss of SW sleep, decrease in sigma spindles and increase in brief arousals indicate that the acute effects of reserpine on human sleep are in the direction of activation, and the persistence of most of these alterations into the P-M session implies that they are due to depletion of one or both monoamines. However, comparison of reserpine effects on sleep with those induced by precursors and blockers of serotonin, and by monoamine oxidase inhibitors suggests that the loss of SW sleep may have resulted from depletion of serotonin, whereas acceleration of the REM cycle may have been caused by a compensatory increase in its rate of synthesis.
Similar content being viewed by others
References
Ashcroft, G. W., Eccleston, D., Crawford, T. B. B.: 5-Hydroxyindole metabolism in rat brain. (Methods.) J. Neurochem. 12, 483–492 (1965).
Bertler, A., Carlsson, A., Rosengren, E.: Release by reserpine of catecholamines from rabbits' hearts. Naturwissenschaften 43, 521 (1956).
Brodie, B. B., Comer, M. S., Costa, E., Dlabac, A.: The role of brain serotonin in the mechanism of the central action of reserpine. J. Pharmacol. exp. Ther. 152, 340–349 (1966).
—, Pletsher, A., Shore, P. A.: Evidence that serotonin has a role in brain function. Science 122, 968 (1955).
Carlsson, A., Lindquist, M., Magnusson, T.: 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature (Lond.) 180, 1200 (1957).
Delorme, F., Jeannerod, M., Jouvet, M.: Effects remarquables de la resérpine sur l'activité EEG phasique ponto-geniculo-occipitale. C.R. Soc. Biol. (Paris) 159, 900 (1965).
Dement, W. C.: The biological role of REM sleep (Circa 1968). In: Sleep, Physiology and Pathology, pp. 245–265. A. Kales, ed. Philadelphia, Pa.: J. P. Lippincott Co. 1969.
—, Kleitman, N.: Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroenceph. clin. Neurophysiol. 9, 673–690 (1957).
Hartmann, E.: Reserpine: Its effect on the sleep-dream cycle in man. Psychopharmacologia (Berl.) 9, 242–247 (1966).
—: The sleep-dream cycle and brain serotonin. Psychon. Sci. 8, 295–296 (1967).
—: Antidepressants and sleep: Clinical and theoretical implications. In: Sleep, Physiology and Pathology, pp. 308–316. A. Kales, ed. Philadelphia, Pa.: J. P. Lippincott Co. 1969.
Hess, S. M., Doepfner, W.: Behavioral effects and brain amine content in rats. Arch. int. Pharmacodyn. 134, 89–99 (1961).
Hoffman, J. S., Domino, E.: Comparative effects of reserpine on the sleep cycle of man and cat. J. Pharmacol. exp. Ther. 170, 190–198 (1969).
Holzbauer, M., Vogt, M.: Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J. Neurochem. 1, 8–11 (1956).
Jouvet, M.: Mechanisms of the states of sleep. In: Sleep and Altered states of Consciousness. S. S. Kety, E. V. Evarts, and H. L. Williams, eds. Baltimore: The Williams and Wilkins Co. 1967.
—: Biogenic amines and states of sleep. Science 163, 32–40 (1969).
Khazan, N., Sawyer, C. H.: Mechanisms of paradoxical sleep as revealed by neurophysiologic and pharmacologic approaches in the rabbit. Psychopharmacologia (Berl.) 5, 457–466 (1964).
Koella, W. P.: The mode and locus of action of serotonin in its effects on the recruiting responses and the EEG of cats. Amer. J. Physiol. 211, 926–934 (1966).
Lester, B. K., Chanes, R. E., Condit, P. T.: A clinical syndrome and EEG-sleep changes associated with amino acid deprivation. Amer. J. Psychiat. 126, 185–190 (1969).
Lubin, A.: L'utilisation des corrélations par rang pour éprouver une tendance dans un ensemble de moyennes. Bull. Cent. Etud. Rech. Psychotech. 10, 433–444 (1961).
Lyerly, S. B.: The average Spearman rank correlation coefficient. Psychometrika 17, 421–428 (1952).
Mandell, M. P., Mandell, A. J., Jacobson, A.: Biochemical and neurophysiological studies of paradoxical sleep. Recent Advanc. Biol. Psychiat. 7, 115–122 (1964).
Matsumoto, J., Jouvet, M.: Effects de réserpine, DOPA et 5-HTP sur les deul etats de sommeil. C.R. Soc. Biol. (Paris) 158, 2137–2140 (1964).
Moir, A. T. B., Eccleston, D.: The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 15, 1093–1108 (1968).
Monnier, M., Tissot, R.: Action de la réserpine et de ses mediateurs (5-HTP, serotonin et DOPA-noradrenaline) sur le comportement et le cerveau du lapin. Helv. physiol. pharmacol. Acta 16, 225 (1958).
Neff, N. H., Tozer, T. N.: In vivo measurement of brain serotonin turnover. In: Advances in Pharmacology, Biological Role of Indolealkylamine Derivatives, vol.6, Part A, pp. 97–109. S. Garattini and P. A. Shore, eds., E. Costa and M. Sandler, assoc. eds. New York: Academic Press 1968.
Oswald, I., Ashcroft, G. W., Berger, R. J., Eccleston, D., Evans, J. I., Thacore, V. R.: Some experiments in the chemistry of normal sleep. Brit. J. Psychiat. 112, 391–399 (1966).
Pscheidt, G. R., Morpurgo, C., Himwich, H.: Studies on norepinephrine and 5-hydroxytryptamine in various species. In: Comparative Neurochemistry, pp. 401 to 412. D. Richter, ed. New York: Pergamon Press 1964.
Rechtschaffen, A., Kales, A., eds.: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institutes of Health Publication No. 204 (1968).
Reite, M., Pegram, G. V., Stephens, L. M., Bixler, E. C., Lewis, O. L.: The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey. Psychopharmacologia (Berl.) 14, 12–17 (1969).
Shore, P. A., Pletscher, A., Tomich, E. G., Carlsson, A., Kuntzman, R., Brodie, B. B.: Role of brain 5-HT in reserpine action. Ann. N. Y. Acad. Sci. 66, 609–615 (1957).
Tissot, R.: The effects of certain drugs on the sleep cycle in man. In: Progress in Brain Research, vol. 18, pp. 175–177. K. Akert, C. Bally, and J. P. Schade, eds. New York: Elsevier 1965.
Torda, C.: Biochemical and bioelectrical processes related to sleep, paradoxical sleep and arousal. Psychol. Rep. 24, 807–824 (1969).
Tozer, T. N., Neff, N. H., Brodie, B. B.: Application of steady state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpine-treated rats. J. Pharmacol. exp. Ther. 153, 177–182 (1966).
Williams, H. L., Lester, B. K., Coulter, J. D.: Monoamines and the EEG stages of sleep. Activ. nerv. sup. (Praha) 11, 188–192 (1969).
Author information
Authors and Affiliations
Additional information
This study was supported in part by USPHS grant No. MH 10844-05 of the National Institute of Mental Health.
We thank Orvis H. Rundell, William J. Griffiths and Lawrence C. Cowden for their technical assistance and management of subjects, and Rosa Coulter for her contributions to analysis of data.
Rights and permissions
About this article
Cite this article
Coulter, J.D., Lester, B.K. & Williams, H.L. Reserpine and sleep. Psychopharmacologia 19, 134–147 (1971). https://doi.org/10.1007/BF00402637
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402637